# Inbiose: Biotechnology, Ghent, Belgium

> Inbiose: “Dedicated to specialty carbohydrates for human health and beyond” Inbiose is dedicated to improving human health by making specialty...

Source: https://millionrounds.com/startup/inbiose (Millionrounds; every figure on the page links to its filing or article)

Belgium · [Biotechnology startup](https://millionrounds.com/companies)

# Inbiose

“Dedicated to specialty carbohydrates for human health and beyond” Inbiose is dedicated to improving human health by making specialty oligosaccharides available for mainstream use.

Funding reported Last round: Debt financing

Biotechnology Ghent, Belgium

Company summary

- **Founded:** 2013 13 years old
- **Team:** 55 51 to 200 people
- **Funding reported:** 17.7M as listed, currency not stated
- **Last round:** Debt financing Jul 2021

How sure we are

- ✓ **Listed** We know it exists and what it does
- 2 **Funding reported** A company dataset reports a raise
- 3 **Observed** A filing or a dated announcement confirms a round

No round for Inbiose has been confirmed by a filing or an announcement yet, so nothing here counts toward an investor's record. [How we decide](https://millionrounds.com/methodology)

## About Inbiose

“Dedicated to specialty carbohydrates for human health and beyond” Inbiose is dedicated to improving human health by making specialty oligosaccharides available for mainstream use.

We strive to make available to the consumer the health benefits these complex sugars can bring to human and infant health, as well as specialized nutrition, cosmetics and beyond. Inbiose is a leading company in the development of Human Milk Oligosaccharides, which are of paramount importance for the health of newborns and developing infants. Our competences lie in the rapid development and cost-effective production of innovative specialty carbohydrates otherwise unavailable to society at large. Our development pipeline allows us to offer a high-throughput development platform, as well as process development, scale-up and regulatory services that compressing new product development cycles and minimizes time to market.

## What company datasets say Inbiose raised

Funding, as reported

Reported in all **17.7M** in the source's currency

Rounds **1**

Last round **Debt financing**

Last round date **Jul 2021**

Investors listed **1**

## Biotechnology in Belgium

Startups like it

- [**Ra Pharmaceuticals** founded 2008](https://millionrounds.com/startup/ra-pharmaceuticals)
- [**eTheRNA immunotherapies** Niel · founded 2013](https://millionrounds.com/startup/etherna-immunotherapies)
- [**ExeVir Bio** Zwijnaarde · founded 2020](https://millionrounds.com/startup/exevir-bio)
- [**Mycorena** Gothenburg · founded 2017](https://millionrounds.com/startup/mycorena)
- [**Complix** Diepenbeek · founded 2008](https://millionrounds.com/startup/complix)
- [**Rewind Therapeutics** Leuven · founded 2017](https://millionrounds.com/startup/rewind-therapeutics)
- [**UgenTec** Hasselt · founded 2014](https://millionrounds.com/startup/ugentec)
- [**Ovizio** Brussels · founded 2010](https://millionrounds.com/startup/ovizio)

## Is this your company?

Add your raise, your deck and your story, and put Inbiose in front of investors. Or tell us what we have wrong.

[List your startup](https://millionrounds.com/list-your-startup)[Send a correction](https://millionrounds.com/corrections)